The di a me ter of pu ri fi ed pro te in de ri va ti ve skin test (PPD) in du ra ti on in eva lu a ti on of po si ti ve re ac ti on va ri es ac cor ding to pa ti ent's im mu ne sta tus, li ving are a and BCG vacci na ti on. A ne ed le prick tra u ma and PPD ex tract may le ad to Ko eb ner phe no me non af ter 72 ho urs and the se app li ca ti ons may be the ca u se of fal se po si ti ve or in cre a se of di a me ter of PPD re ac ti on in pso ri a tic pa ti ents. The aim of the study was to eva lu a te the re sults of PPD skin test in pso ri a tic pa tients and to com pa re with con trol sub jects. M Ma a t te e r ri i a al l a an nd d M Me et t h ho od ds s: : The test was per for med on 117 con se cu ti ve pa ti ents with pso ri a sis vul ga ris and 102 im mu no com pe tant con trol pa ti ents. The Manto ux met hod was used for the test and skin re ac ti on was me a su red at 72 ho urs. A po si ti ve skin re acti on was con si de red > 10 mm. R Re e s su ul lt ts s: : A po si ti ve PPD test was de tec ted in 49 pso ri a tic pa ti ents (41.8%) and in 31 of the con trol sub jects (30.3%). Dif fe ren ces in po si ti ve PPD re ac ti ons (p=0.16) and the di a me ter of PPD in du ra ti ons (p=0.36) bet we en two gro ups we re not sta tis ti cally sig ni fi cant. The di a me ter of PPD in du ra ti ons in pso ri a tic pa ti ents was not as so ci a ted with sex, du ra ti on of the di sea se or pso ri a sis are a and se ve rity in dex sco re (p> 0.05). C Co on nc c l lu u s si i o on n: : Our re sults show that pso ri a sis has no ef fect on the PPD skin test. We think that this test is ap prop ri a te to re cog ni ze la tent tu bercu lo sis in fec ti on in pa ti ents with pso ri a sis un til mo re sen si ti ve di ag nos tic tests be co me ava i lab le.
PD skin test is used widely in detection of latent tuberculosis infection (LTBI)
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K Ke ey y W Wo or rd ds s: : Pso ri a sis; tu ber cu lo sis Ö ÖZ ZE ET T A Am ma aç ç: : Po zi tif bir re ak si yo nun de ğer len dir me sin de PPD ( saf laş tı rıl mış pro te in tü re vi= Puri fi ed Pro te in De ri va ti ve) de ri tes ti en dü ras yo nu nun ça pı has ta nın im mun du ru mu na, ya şa dı ğı yer ve BCG aşı lan ma sı na gö re de ğiş ken lik gös ter mek te dir. İğ ne trav ma sı ve PPD par ti kül le ri 72 sa at son ra Ko eb ner fe no me ni ne yol aça bi lir ve bu uy gu la ma pso ri a tik has ta lar da yan lış po zi tif li ğe ve ya PPD re ak si yon ça pın da ar tı şa ne den ola bi lir. Bu ça lış ma nın ama cı pso ri a tik has ta lar da PPD de ri tes ti nin so nuç la rı nı de ğer len dir mek ve kon trol gru buy la kar şı laş tır mak tır. G Ge e r re eç ç v ve e Y Yö ön n t te em m l le er r: : Test ar dı şık 117 pso ri a sis vul ga ris li has ta ya ve 102 im mun ola rak sağ lam kon trol has ta sı na uy gulan dı. Test için Man to ux me to du kul la nıl dı ve de ri re ak si yo nu 72. sa at te öl çül dü. Po zi tif de ri re aksi yo nu > 10 mm ola rak ka bul edil di. B Bu ul l g gu u l la ar r: : Po zi tif PPD tes ti 49 pso ri a tik has ta da (%41.8) ve 31 kon trol has ta sın da (%30.3) sap tan dı. İki grup ara sın da po zi tif PPD re ak si yo nu (p= 0.16) ve PPD endü ras yon ça pın da (p= 0.36) is ta tis tik sel ola rak fark sap tan ma dı. Pso ri a tik has ta lar da PPD en dü rasyo nu nun ça pı cin si yet, has ta lık sü re si ve psö ri a zis alan ve şid det in deks sko ru ile iliş ki li de ğil di (p> 0.05). S So o n nu uç ç: : So nuç la rı mız pso ri a si sin PPD de ri tes ti üze ri ne her han gi bir et ki ye sa hip ol ma dı ğı nı gös ter di. Biz bu tes tin pso ri a sis li has ta lar da da ha du yar lı ta nı sal test ler el de edi le ne ka dar la tent tü-ber kü loz en fek si yo nu nu ta nım la ma da uy gun ol du ğu nu dü şü nü yo ruz. cal ac ti vity of TNF-α star ted to be used in the treat ment of rhe u ma to lo gi cal di sor ders and pso ri a sis vul ga ris. One of ma jor prob lems of the se agents is appearance of tu ber cu lo sis in fec ti on. It is re commen ded that the risk of LTBI sho uld be eva lu a ted by a PPD skin test be fo re ini ti a ting an ti-TNF-α the rapy. 1 The di a me ter of in du ra ti on of po si ti ve PPD skin test is ac cep ted as 10 mm in co un tri es whe re BCG vac ci na ti on is used ro u ti nely. Ho wever a high in ci den ce of anergy has be en re por ted in so me rhe u ma to lo gic di se a ses. For this re a son, it is sug ges ted that this po si ti ve di a me ter of in du ra tion sho uld be dec re a sed to 5 mm in rhe u ma to lo gical di sor ders.
2,3
The Ko eb ner phe no me non is a known con diti on in pso ri a sis, and all tra u ma tic pro cess may lead to this phe no me non. The re por ted in ci den ce of Ko eb ner res pon se in pso ri a sis va ri es from 11-75%. The la tent pe ri od bet we en in jury to unin vol ved skin and ap pe a ran ce of di se a se is usu ally 10-14 days, but it may ran ge from three days to se ve ral ye ars. 4 A ne ed le prick tra u ma and PPD ex tract may le ad to Ko eb ner phe no me non af ter 72 ho urs and the se app li ca ti ons may be the ca u se of fal se po si tive PPD re ac ti on in pso ri a tic pa ti ents. On the ot her hand, pso ri a sis is an im mu no lo gi cally me di a ted di se a se ca u sed by ac ti va ti on of T lymphocy tes and many the ra pe u tic agents such as cyclos po ri ne in pso ri a sis work pri ma rily thro ugh in hi bi ti on of T cell ac ti va ti on. Alteration of T cell func ti on in psori a tic pa ti ents may re sult in ina bi lity to pro du ce an ade qu a te res pon se to the PPD test, which is a T cell me di a ted type IV re ac ti on. Ho we ver the re is no information abo ut as ses sing this skin test in pso ri a tic pa ti ents. The pur po se of this re port was to eva lu ate the PPD re ac ti vity and ef fects of Ko eb ner pheno me non on this skin test in pso ri a tic pa ti ents and and to com pa re it with im mu no com pe tant con trol pa ti ents.
MA TE RI AL AND MET HODS
The study was con duc ted on 117 con se cu ti ve un rela ted pa ti ents with pso ri a sis vul ga ris (56 ma les, 61 fe ma les; me an ± SD age 35.4 ± 13.4 ye ars, ran ge 16-67 ye ars) and 102 un re la ted con trol sub jects (47 males, 55 fe ma les; 35.9 ± 12.4 ye ars, ran ge 16-65 ye ars), at ten ded out pa ti ent der ma to logy cli nic bet we en April 2006 and July 2007. Con trol sub jects con sis ted of im mu no com pe tent pa ti ents di ag no sed with ti ne a pe dis, pal mop lan tar warts, in sect bi tes, ma le or fema le an dro ge ne tic alo pe ci a, ac ne vul ga ris, se borrho e ic der ma ti tis, ac ti nic ke ra to sis, corn and cal lus. HIV test was ne ga ti ve in the con trol sub jects with warts, ti ne a and se borr ho e ic der ma ti tis. . Pa ti ents older than 15 ye ars old were ,ncluded ,nto both study and the control groups. Exc lu si on cri te ri a we re the pre sen ce of a di se a se as so ci a ted with non-spe ci fic im mu no sup pres si on (li ver or re nal di se a se, sar co ido sis, di a be tes, mal nut ri ti on, and ma lig nant di se ases), use of im mu no sup pres si ve drugs, ac ti ve tu ber cu lo sis, known hyper sen si ti vity to PPD, acu te in fec ti ons, and po si ti ve se ro logy for HIV. In ad di tion, pso ri a tic pa ti ents who we re tre a ted with an immu no sup pres si ve agent, PU VA, UVB, nar row band UVB in last three months, and pa ti ents we re tre a ted with acit re tin in last two ye ars were not included in the study. Per son nel and pso ri a tic pa ti ents wor king in hos pi tal we re not inc lu ded in the study. PPD was per for med using the Man to ux met hod [ Özdemir ve ark. Dermatoloji ve Veneroloji unit (0.1 ml) was in jec ted in tra der mally by 26G dispo sab le ne ed le] and was eva lu a ted by me a su ring the di a me ter of in du ra ti on (not ery the ma) 72 ho urs later. In ad di ti on to PPD test, a ne ed le prick and injection of 0.1 ml physi o lo gi cal sa li ne we re per for med in tra der mally by using a 26G dis po sab le ne ed le in or der to eva lu a te fal se po si ti ve of PPD test and Koeb ner phe no me non. All app li ca ti ons we re per formed to ha ir less vo lar si te on the fo re arm by the sa me physi ci an (MÖ) and the test are as we re me a su red trans ver sely to the long axis of the fo re arm using the pen met hod by the sa me ob ser ver (BE). PPD test was con si de red po si ti ve if a re ac ti ve in du ra ti on ex ce e ded 10 mm in di a me ter. Ab nor mal skin fin dings such as pus tu le or pa pu los qu a mo us le si on on the test are a we re no ted at eva lu a ti on. Pa ti ents who had the Koeb ner phe no me non be fo re the test we re no ted. BCG vac ci na ti on was re cor ded in a per so nal in ter vi ew and by ve rif ying its scar. Du ra ti on of the di se a se, and pso ri a sis are a and se ve rity in dex (PA SI) sco re we re re cor ded in the pa ti ents with pso ri a sis vul ga ris. The pro to col was ap pro ved by the ins ti tu ti o nal et hics com mit te e, and all sub jects sig ned an in for med consent form.
For sta tis ti cal analy sis, Mann-Whit ney U test, χ 2 test and Spe ar man's cor re la ti on co-ef fi ci ent were used.
RE SULTS
The tests we re per for med on the an te ri or re gi on of the brac hi um in fi ve pa ti ents with pso ri a sis be ca use of wi des pre ad pso ri a tic le si ons on their fo re arms. BCG scar was de tec ted in 107 pso ri a tic pa ti ents (91.4%) and 88 con trol sub jects (86.2%). The re were no sig ni fi cant dif fe ren ces bet we en pa ti ents with pso ri a sis and con trols in age (p= 0.72), sex (p=0.79) or BCG vac ci na ti on (p= 0.31). The me di an (IQR: in ter qu ar ti le ran ge) di a me ter of in du ra ti on on the PPD prick si te in the pso ri a tic pa ti ents and con trols we re 7 (6) mm and 7 (6) mm, res pec ti vely (p=0.36) (Tab le 1). Po si ti ve PPD test was de tec ted in 49/117 pso ri a tic pa ti ents (41.8%) and in 31/102 in the control gro up (30.3%) (p= 0.16) (Fi gu re 1). BCG scar was de tec ted in all PPD po si ti ve sub jects ex cept for two pso ri a tic pa ti ents. Twenty two sub jects (eight pso ra tic and 14 con trol pa ti ents) who had no BCG scar we re ne ga ti ve for PPD test. Six te en (13.6%) pso ri a tic pa ti ents sho wed no re ac ti on to PPD (0 mm) com pa red with 20 sub jects (19.6%) in the con trol gro up (p= 0.25) (Tab le 2).
Ko eb ner phe no me non was de tec ted in 11 pati ents (9.4%) be fo re the test (Tab le 3). Po si ti ve PPD test was de tec ted in five of 11 pa ti ents. The me dian (IQR) di a me ter of in du ra ti on on the PPD prick si te in the Ko eb ner-po si ti ve and ne ga ti ve pa ti ents we re 8 (8) mm and 7 (6) mm, res pec ti vely (p=0.75). Anergy was not de tec ted in the Ko eb ner-po si ti ve pa ti ents. The phe no me non at ot her two test si tes in the se pa ti ents was not se en (Fi gu re 2). An erythe ma to us pla qu e with pus tu les lo ca ted on the edge of the pla qu e was se en in a Ko eb ner-ne ga ti ve pa ti ent who did not have any re ac ti ons at the ot her two tests are as. A pa pu los qu a mo us le si on only at the ne ed le prick si te was de tec ted in a Ko eb nerne ga ti ve pa ti ent who had no re ac ti on to the physi o lo gi cal sa li ne and PPD (Fi gu re 3). Mi ni mal ery the ma at the physi o lo gi cal sa li ne and only ne ed le prick si tes we re se en in three Ko eb ner-ne ga tive pa ti ents (Fi gu re 4). We in ter pre ted the se no nin du ra ti ve le si ons as a Ko eb ner re ac ti on.
We performed an analysis to de ter mi ne whether the di a me ter of PPD in du ra ti on was inf lu enced by fac tors such as du ra ti on of the di se a se and PA SI sco re in pso ri a tic pa ti ents. The me an ± SD di se a se du ra ti on and PA SI sco re we re 12.6 ± 9.8 ye ars and 9.8 ± 7.9, res pec ti vely. The ran ge of PA SI score and du ra ti on of the di se a se we re 0.4-36.2 and 6 months-40 ye ars, res pec ti vely. Ho we ver, the di ame ter of PPD in du ra ti on was not as so ci a ted with sex (p= 0.20), du ra ti on of the di se a se (r s = 0.01, p= 0.90) or PA SI sco re (r s = 0.07, p= 0.40). The re was no as so ci a ti on bet we en the po si ti ve PPD test and PA -SI sco re.
Po si ti ve PPD test was not as so ci a ted with age in pso ri a tic (p= 0.47) and con trol pa ti ents (p= 0.95). In 23 pa ti ents with pso ri a sis and 12 con trol pa tients, the du ra ti on of BCG vac ci na ti on was un der 15 ye ars. A po si ti ve PPD test was de tec ted in 10 of 23 pa ti ents with pso ri a sis and four of 12 con trol pati ents. All of them had BCG scars. Chest X rays were performed in all sub jects with po si ti ve PPD tests. So me fin dings such as pa rench ymal ab nor -
Dermatology and Venerology
Özdemir et al ma li ti es and gra nu lo ma li ke le si ons on the chest X ray for la tent tu ber cu lo sis we re de tec ted by a pneu mo lo gist in only 8 pa ti ents with pso ri a sis (16.3%) and one sub ject in the con trol gro up (16.1%).
DIS CUS SI ON
In this ca se-con trol study, PPD test was eva lu a ted in pso ri a tic and con trol pa ti ents. A po si ti ve PPD test re sult has be en re por ted to vary from 0% to 90% in many stu di es from dif fe rent co un tri es. 5 PPD re ac tion can be inf lu en ced by so me vi ral di se a ses, me tabo lic di sor ders, pro te in de fi ci en ci es, lympho id tis su e di sor ders and drugs. BCG gi ves so me pro tecti on aga inst tu ber cu lo sis and le ads to a po si ti ve PPD skin test. In Tur key, BCG vac ci na ti on was per formed in the first in two months of age and at the age of 7 ye ars. The re is no re li ab le met hod to dis tin guish bet we en a po si ti ve PPD re ac ti on as so ci a ted with vac ci na ti on and M. tu ber cu lo sis in fec ti on. Ho wever, in a me ta-analy sis, it was de mons tra ted that when the PPD test is ta ken 15 ye ars or later af ter BCG vac ci na ti on, the vac ci na ti on do es not ha ve any inf lu en ce on PPD re ac ti on. 5 In a re cent study from Tur key, it was found that BCG scars did not have any influence on PPD re ac ti on authors suggested that in adults and they sug ges ted that a po si ti ve PPD res pon se in adults li ving in high-pre va len ce co untri es might be du e to LTBI rat her than pre vi o us BCG vac ci na ti on. 6 In 35 sub jects the du ra ti on of BCG vac ci na ti on was un der 15 ye ars in the pre sent study, and 14 of them (40%) had po si ti ve PPD test. Ho we ver, the re was an ab nor ma lity on chest X ray for la tent tu ber cu lo sis in 14 pa ti ents. We fo und a slight in cre a se in po si ti ve PPD skin test (41.8%) in the pso ri a tic pa ti ents however this was not sta tis tically sig ni fi cant. This slight high po si ti ve ra te may be as so ci a ted with ex ces si ve use of im mu no suppres si ve agents and/or a long con tact or hos pi ta liza ti on ti me in pso ri a tic pa ti ents than the con trol pa ti ents. Cross-re ac ti ons ca u sed by the pre sen ce of aty pi cal myco bac te ri a is anot her pos si bi lity, but the re is li mi ted da ta in Tur key.
A ne ga ti ve re ac ti on to PPD (anergy) is de tected in sub jects who are not in fec ted or unab le to de ve lop a de la yed hyper sen si ti ve skin re ac ti on. Howe ver, a high in ci den ce of anergy has be en re ported in so me vi ral and im mu no lo gic di sor ders such as rhe u ma to id art hri tis and inf lam ma tory bo wel dise a se. 2 We did not de tect a sta tis ti cally sig ni fi cant dif fe ren ce bet we en the pso ri a tic pa ti ents and the con trol for anergy. The Ko eb ner phe no me non is a known con di ti on in pso ri a sis and all tra u ma tic conditions may le ad to this phe no me non. The re por ted in ci den ce of Ko eb ner res pon se in pso ri a sis va ri es between 11-75%. The la tent pe ri od bet we en in jury to unin vol ved skin and ap pe a ran ce of di se a se is usu ally 10-14 days, but it may ran ge from three 4 A ne ed le prick tra u ma and PPD ex tract may le ad to Ko eb ner phe no me non after 72 ho urs and the se app li ca ti ons may be the cau se of fal se po si ti ve PPD re ac ti on in pso ri a tic pa ti ents. In the pre vi o us stu di es, an as so ci a ti on bet we en in tra der mal an ti gen tests (PPD, Can di da, mumps, e.g.) and the Ko eb ner phe no me non was not de tec ted in pso ri a sis. This phe no me non was ob ser ved at all in jec ti on si tes in three of of 42 psori a tic pa ti ents and one of the thre e pa ti ents was Koeb ner-po si ti ve pso ri a tic sub ject in the se stu di es. 7, 8 We ob ser ved this phe no me non at a ne ed le prick site and a PPD in jec ti on si te in two pa ti ents with pso ri a sis who we re Ko eb ner-ne ga ti ve. In te restingly, Ko eb ner phe no me non or any re ac ti on was not de tec ted at the PPD and physi o lo gi cal sa li ne in jec ti on si tes in the only ne ed le prick si te Ko eb ner po si ti ve pa ti ent, and at the ne ed le prick and sa li ne in jec ti on si tes in the PPD in jec ti on si te Ko eb ner po si ti ve pa ti ent. We did not se e the Ko eb ner pheno me non at all test si tes in our 11 Ko eb ner-po si tive pa ti ents and po si ti ve PPD test was de tec ted in five of them. In ad di ti on, the re is no sta tis ti cally sig ni fi cant dif fe ren ce in the di a me ter of in du ra ti on on the PPD prick si te between the Ko eb ner-po si tive and ne ga ti ve pa ti ents. We believe that Ko eb ner phe no me non may play a li mi ted ro le on the po siti ve PPD test. Ho we ver this test sho uld be eva lu ated in lar ge se ri es of Ko eb ner-po si ti ve pa ti ents.
In conc lu si on, per so nal im mu ne sta tus and local epi de mi o lo gi cal da ta are very im por tant fac tors in in ter pre ta ti on of a po si ti ve PPD test in a per son. The high po si ti ve PPD ra tes in this study may be re sult of the high pre va len ce of tu ber cu lo sis in Turkey. Ho we ver, PPD positivity ra te was not fo und hig her or lo wer in the pso ri a tic pa ti ents when compared to the con trols. This fin ding shows that psori a sis and the Ko eb ner phe no me non do not inf lu en ce the PPD re ac ti on, and po si ti ve PPD test in a pso ri a tic pa ti ent li ving in high-pre va len ce coun tri es may be related to la tent tu ber cu lo sis rat her than the BCG vac ci na ti on. We sug gest that PPD skin test is ap prop ri a te to re cog ni ze LTBI in pso ria tic pa ti ents who will be tre a ted with the bi o lo gic or ot her syste mic agents, un til mo re sen si ti ve di agnos tic tests are ava i lab le. 
